Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Combination treatment with azidothymidine and granulocyte colony-stimulating factor in children with human immunodeficiency virus infection.

Mueller BU, Jacobsen F, Butler KM, Husson RN, Lewis LL, Pizzo PA.

J Pediatr. 1992 Nov;121(5 Pt 1):797-802.

PMID:
1279153
2.

Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine.

Miles SA, Mitsuyasu RT, Moreno J, Baldwin G, Alton NK, Souza L, Glaspy JA.

Blood. 1991 May 15;77(10):2109-17.

3.

Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF.

Weisdorf DJ, Verfaillie CM, Davies SM, Filipovich AH, Wagner JE Jr, Miller JS, Burroughs J, Ramsay NK, Kersey JH, McGlave PB, et al.

Blood. 1995 Jun 15;85(12):3452-6.

4.
7.

Disposition of recombinant human granulocyte colony-stimulating factor in children with severe chronic neutropenia.

Kearns CM, Wang WC, Stute N, Ihle JN, Evans WE.

J Pediatr. 1993 Sep;123(3):471-9.

PMID:
7689097
8.
9.
10.
11.
12.

Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support.

de Wit R, Verweij J, Bontenbal M, Kruit WH, Seynaeve C, Schmitz PI, Stoter G.

J Natl Cancer Inst. 1996 Oct 2;88(19):1393-8.

PMID:
8827017
13.
15.

Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study.

Rackoff WR, Orazi A, Robinson CA, Cooper RJ, Alter BP, Freedman MH, Harris RE, Williams DA.

Blood. 1996 Sep 1;88(5):1588-93.

16.

Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection.

Pizzo PA, Butler K, Balis F, Brouwers E, Hawkins M, Eddy J, Einloth M, Falloon J, Husson R, Jarosinski P, et al.

J Pediatr. 1990 Nov;117(5):799-808.

PMID:
2172501
17.
18.

Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.

Hassan HT, Krog C, Stockschl├Ąder M, Schleimer B, Zeller W, Kr├╝ger W, Erttmann R, Zander AR.

Anticancer Res. 1997 Jan-Feb;17(1B):589-99.

PMID:
9066585

Supplemental Content

Support Center